PathoQuest Announce the Opening of its New U.S. Facility

PathoQuest Announce the Opening of its New U.S. Facility The Leading Experts in NGS Biosafety Testing and Characterization of Biopharmaceuticals Launch New Capabilities in the Critical U.S. Market Wayne, PA, and Paris, France – October 4, 2022 – PathoQuest, a leader...

PathoQuest Appoints Eric Cazergue as Chief Financial Officer

PathoQuest Appoints Eric Cazergue as Chief Financial Officer PARIS, FRANCE — April 06, 2021 – PathoQuest, a pioneer of Next Generation Sequencing (NGS)-based testing solutions for the quality control of biologics, today announced the appointment of Eric Cazergue as...